Thursday, March 20, 2014
Publication and contact
macrophages as diagnostic markers for metastasizing tumors
Human sample studies
suggest detection of circulating giant macrophages could be used to predict
solid tumor metastasis. In blood samples from a cohort of 79 patients with
breast, prostate or pancreatic cancer, a low-pressure filtration system with
precision microfilters isolated cancer-associated, macrophage-like cells
(CAMLs) with giant cellular morphology and large, atypical nuclei in 83%-97%
of the samples. CAMLs were positive for markers from engulfed cancer cells
and markers from angiogenic endothelial cells, and in 10% of the cases the
cells were associated with circulating tumor cells. Next steps include
identifying clinical applications for CAML measurements such as assessing
tumor responses to specific therapy.
Creatv MicroTech Inc.
markets the CellSieve microfiltration assay to isolate CAMLs.
Published online March 20, 2014
application filed; available for licensing
Adams, D.L. et al. Proc.
Natl. Acad. Sci. USA; published online Feb. 18, 2014;
Contact: Daniel L. Adams, Creatv MicroTech Inc., Rockville, Md.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]